Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Efficacy of Vindesine + Dexamethasone (VDS+Dexa.) in Elderly Patients with Relapsed or Refractory Malignant Lymphoma

Hiromi Yuasa, MD PhD, Hisashi Wakita, MD, Yasuhiro Matsuura, MD, Shunichirou Inagaki, MD, Hironori Arai, MD, Yoshikazu Utsu, MD, Shinichi Masuda, MD, Nobuyuki Aotsuka, MD, Shosuke Sunami, MD PhD

Blood (2015) 126 (23): 5061.

https://doi.org/10.1182/blood.V126.23.5061.5061

Published: 2015

Journal Articles

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Taiichi Kyo, MD, Noriaki Yoshida, MD, Kouhei Kyo, MD, Takeshi Okatani, MD, Mitsuhiro Itagaki, MD, Hiromi Yuasa, MD, Koji Iwato, MD, Hideki Asaoku, MD, Yuuta Katayama, MD

Blood (2010) 116 (21): 2934.

https://doi.org/10.1182/blood.V116.21.2934.2934

Published: 2010

Journal Articles

Cytomegalovirus Infection in Patients with Acute Leukemia and MDS.

Hiromi Yuasa, M.D., Ph.D., Taiichi Kyo, MD, Noriaki Yoshida, MD, Yuta Katayama, Hideki Asaoku, MD

Blood (2009) 114 (22): 4167.

https://doi.org/10.1182/blood.V114.22.4167.4167

Published: 2009

Journal Articles

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Taiichi Kyo, MD, Akiko Kimura, MD, Kouhei Kyo, MD, Noriaki Yoshida, MD, Hideki Asaoku, MD, Koji Iwato, MD, Yuuta Katayama, MD, Hiromi Yuasa, MD

Blood (2009) 114 (22): 1052.

https://doi.org/10.1182/blood.V114.22.1052.1052

Published: 2009

Journal Articles

Oncogenic Transcription Factor Evi1 Regulates Hematopoietic Stem Cell Proliferation through GATA-2 Expression.

Hiromi Yuasa, Yuichi Oike, Atsushi Iwama, Daisuke Sugiyama, Ichiro Nishikata, Archibald S. Perkins, Micheal L. Mucenski, Kazuhiro Morishita, Toshio Suda

Blood (2004) 104 (11): 228.

https://doi.org/10.1182/blood.V104.11.228.228

Published: 2004

NARROW

Efficacy of Vindesine + Dexamethasone (VDS+Dexa.) in Elderly Patients with Relapsed or Refractory Malignant Lymphoma

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Cytomegalovirus Infection in Patients with Acute Leukemia and MDS.

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Oncogenic Transcription Factor Evi1 Regulates Hematopoietic Stem Cell Proliferation through GATA-2 Expression.

Email alerts

ASH Publications

American Society of Hematology

Efficacy of Vindesine + Dexamethasone (VDS+Dexa.) in Elderly Patients with Relapsed or Refractory Malignant Lymphoma

Treatment Results of Intensive Chemotherapy for Higher-Risk Myelodysplastic Syndrome (HR-MDS) and Acute Myeloid Leukemia Related to MDS (MDS-AML)

Cytomegalovirus Infection in Patients with Acute Leukemia and MDS.

High Remission Rates and Long-Term Survival in a High Percentage of Patients Achieved by Intensive Chemotherapy for AML and Further Improvement of Supportive Care.

Oncogenic Transcription Factor Evi1 Regulates Hematopoietic Stem Cell Proliferation through GATA-2 Expression.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only